Back
HFA Premium Access

Machine-learning based exploration of variability of longitudinal myocardial velocities in heart failure with preserved ejection fraction

Session: Poster session 3 - HFpEF - Heart failure with preserved ejection fraction
Topic: HFpEF - Heart failure with preserved ejection fraction
Speaker: Professor B. Bijnens (Barcelona, ES)
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

Like

About the speaker

Professor Bart Bijnens

Universitat Pompeu Fabra, Barcelona (Spain)
9 presentations
4 followers

16 more presentations in this session

Effect of drug treatment on quality of life in heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomised controlled trials

Speaker: Doctor S. Zheng (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Prognostic impact of blood pressure values in patients with heart failure with preserved ejection fraction

Speaker: Doctor M. Goncalves (Viseu, PT)

Access
Abstract
Like
Thumbnail

Exercise training in diastolic heart failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial

Speaker: Doctor A. Feuerstein (Berlin, DE)

Access
Abstract
Like
Thumbnail

Left atrial volume index predicts major adverse cardiovascular events in patients with ischemic chronic heart failure with preserved ejection fraction and renal dysfunction

Speaker: Professor D. Lashkul (Zaporizhzhya, UA)

Access
Like
Thumbnail

The comorbidity in patients with heart failure and preserved ejection fraction depending on age

Access
Like
Thumbnail

Access the full session

Poster session 3 - HFpEF - Heart failure with preserved ejection fraction

Speakers: Professor B. Bijnens, Doctor S. Zheng, Doctor M. Goncalves, Doctor A. Feuerstein, Professor D. Lashkul
Access
Like
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources